Canton Strategic Holdings, Inc.
CNTNNasdaqHealthcare · Pharmaceutical Preparations · DE · SEC filings ↗ · Compare ⊕
View price & chart on Yahoo Finance ↗Financials
SEC XBRL · annual| FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | |
|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — |
| Operating income | −$20.1M | −$12.4M | −$9.5M | −$6.9M | −$3.2M | −$1.8M |
| Net income | −$35.9M | −$12.2M | −$9.3M | −$8.5M | −$2.2M | −$2.4M |
| Total assets | $519.1M | $3.7M | $10.9M | $6.7M | $621,677 | $294,798 |
| Total liabilities | $121.2M | $2.4M | $1.8M | $1.1M | $5.3M | $4.0M |
| Equity | $397.9M | $1.3M | $9.1M | $5.5M | −$4.7M | −$3.7M |
| EPS (diluted) | $-1.12 | $-9.41 | $-107.02 | $-18.72 | $-0.35 | — |
| Shares out. | 2.1M | 11.7M | 11.5M | 11.4M | 6.4M | 6.4M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2025- Operating margin
- —
- Net margin
- —
- Return on equity
- −9.0%
- Return on assets
- −6.9%
- Return on capital (ROCE)
- −3.9%
- Liabilities / assets
- 23.3%
- Debt / equity
- 0.30×
- Book value / share
- $188.70
- Revenue growth (YoY)
- —
- Net income growth (YoY)
- —
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2025- Altman Z″ (distress)
- 2.91safe
- Accruals / assets
- −3.8%clean
- Piotroski F-Score
- 5/7mixed
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast. What these scores mean →
Signs
● 1 severe● 1 warning● 3 good- Filed a late-filing notice (Form NT) — missed an SEC deadline
- Negative operating cash flow
- Conservative leverage (liabilities < 50% of assets)
- Clean earnings (low accruals)
- Altman Z″ in the safe zone
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Risk flags
late SEC filings- NT 10-Qmissed a reporting deadline ↗May 16, 2023
- NT 10-Kmissed a reporting deadline ↗Apr 1, 2022
A Form NT means the company notified the SEC it would file a periodic report late — often an accounting, audit or liquidity warning sign. Also search SEC enforcement actions for this company.
5%+ owners
SEC Schedule 13D / 13G · last 3 yrs- Lcv Fund Viii, L.P.Passive (13G)May 11, 2026
- Broadridge Financial Solutions, Inc.Passive (13G)Feb 6, 2026
- Ark Investment Management LlcPassive (13G)Feb 3, 2026
- Blackrock, Inc.Passive (13G)Jan 21, 2026
- Gravitas Capital LpActivist (13D)Jun 20, 2025
- Gsb Holdings, Inc.Passive (13G)May 23, 2025
Holders who disclosed a 5%+ stake. 13D signals intent to influence or control; 13G is a passive holding. Latest filing per holder — open it for the exact stake.
Short interest
FINRA · bi-monthly| Settlement | Shares short | Days to cover | Δ vs prior |
|---|---|---|---|
| May 15, 2026 | 3.2M | 6.3 | -4.5% |
| Apr 30, 2026 | 3.3M | 6.3 | -7.8% |
| Apr 15, 2026 | 3.6M | 5.1 | +19.3% |
| Mar 31, 2026 | 3.0M | 5.7 | +13.7% |
| Mar 13, 2026 | 2.7M | 5.0 | -8.5% |
Shares sold short as reported to FINRA. Days-to-cover = short shares ÷ average daily volume — higher means more potential squeeze pressure.
Material events
SEC Form 8-K · most recent- Other material eventMar 31, 2026
- Entered a material agreementMar 3, 2026
- Other material eventMar 3, 2026
- Amended charter or bylaws · Regulation FD disclosureFeb 18, 2026
- Director / officer change · Regulation FD disclosure · Other material eventFeb 6, 2026
- Shareholder vote · Other material eventFeb 2, 2026
- Other material eventJan 26, 2026
- Entered a material agreement · Other material eventJan 22, 2026
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗Event-driven situations (3)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.